| Dr Kael Ann Murphy Pettis, MD | |
|
226 S Woods Mill Rd Ste 68w, Chesterfield, MO 63017-3665 | |
| (314) 205-6788 | |
| (314) 590-5954 |
| Full Name | Dr Kael Ann Murphy Pettis |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 226 S Woods Mill Rd Ste 68w, Chesterfield, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831681626 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2018018365 (Missouri) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 2022010838 (Missouri) | Primary |
| Entity Name | West County Women's Healthcare, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447570395 PECOS PAC ID: 2961534417 Enrollment ID: O20100719000438 |
News Archive
Mutation of a gene that helps proteins migrate in and out of the cell's genetic command center - the nucleus - puts some families at higher risk for the degenerative brain disease acute necrotizing encephalopathy (ANE).
Although sharply divided, public attitudes toward gays and lesbians are rapidly changing to reflect greater acceptance, with younger generations leading the way, research by NORC at the University of Chicago shows.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that while Amgen/Stiefel/Pfizer's Enbrel is the most popular biologic across all lines of therapy for psoriasis treatment in newly diagnosed patients, Abbott's Humira is gaining increasing use as a first-line biologic at Enbrel's expense.
Oxygen Biotherapeutics, Inc. announced today that its common stock has been approved for secondary listing on the SIX Swiss Exchange in addition to its listing on the NASDAQ Capital Market. Bank am Bellevue of Zurich is acting as the company's listing agent.
Patients with a certain genetic variation who received the antiplatelet drug clopidogrel had a decreased platelet response to treatment and among those who had percutaneous coronary intervention (procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries) had an increased risk of having a cardiovascular event in the following year than patients who did not have this variant, according to a study in the August 26 issue of JAMA.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kael Ann Murphy Pettis, MD 226 S Woods Mill Rd Ste 68w, Chesterfield, MO 63017-3665 Ph: (314) 205-6788 | Dr Kael Ann Murphy Pettis, MD 226 S Woods Mill Rd Ste 68w, Chesterfield, MO 63017-3665 Ph: (314) 205-6788 |
News Archive
Mutation of a gene that helps proteins migrate in and out of the cell's genetic command center - the nucleus - puts some families at higher risk for the degenerative brain disease acute necrotizing encephalopathy (ANE).
Although sharply divided, public attitudes toward gays and lesbians are rapidly changing to reflect greater acceptance, with younger generations leading the way, research by NORC at the University of Chicago shows.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that while Amgen/Stiefel/Pfizer's Enbrel is the most popular biologic across all lines of therapy for psoriasis treatment in newly diagnosed patients, Abbott's Humira is gaining increasing use as a first-line biologic at Enbrel's expense.
Oxygen Biotherapeutics, Inc. announced today that its common stock has been approved for secondary listing on the SIX Swiss Exchange in addition to its listing on the NASDAQ Capital Market. Bank am Bellevue of Zurich is acting as the company's listing agent.
Patients with a certain genetic variation who received the antiplatelet drug clopidogrel had a decreased platelet response to treatment and among those who had percutaneous coronary intervention (procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries) had an increased risk of having a cardiovascular event in the following year than patients who did not have this variant, according to a study in the August 26 issue of JAMA.
› Verified 8 days ago
Dr. Caroline Anne Morgan, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 226 S Woods Mill Rd, Suite 68 West, Chesterfield, MO 63017 Phone: 314-576-0930 Fax: 314-514-8229 | |
Dr. Stephen C Yim, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 226 S Woods Mill Rd, Suite 55 West, Chesterfield, MO 63017 Phone: 314-469-4440 Fax: 314-576-2346 | |
Dr. Laura Irene Moore, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 224 South Woods Mill Road, Suite 750, Chesterfield, MO 63017 Phone: 314-576-9797 Fax: 314-469-7517 | |
Dr. Joe Edward Belew, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 224 S Woods Mill Rd, Suite 750, Chesterfield, MO 63017 Phone: 314-576-9797 Fax: 314-469-7517 | |
Dr. Jessica Baldetti, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 226 S Woods Mill Rd Ste 68w, Chesterfield, MO 63017 Phone: 314-205-6788 Fax: 314-590-5954 | |
Katherine A Maxson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 226 S Woods Mill Rd, S5w, Chesterfield, MO 63017 Phone: 314-469-0001 | |
Marta I Pineda, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 226 S Woods Mill Rd, Ste 61w, Chesterfield, MO 63017 Phone: 314-205-6957 |